Modifi cation of tissue engineering scaffolds with bioactive molecules is a potential strategy for modulating cell behavior and guiding tissue regeneration. While adhesion to RGD peptides has been shown to inhibit in vitro chondrogenesis, the effects of extracellular matrix (ECM)-mimetic ligands with complex secondary and tertiary structures are unknown. This study aimed to determine whether collagen-and fi bronectin-mimetic ligands would retain biologic functionality in three-dimensional (3D) hydrogels, whether different ECM-mimetic ligands differentially infl uence in vitro chondrogenesis, and if effects of ligands on differentiation depend on soluble biochemical stimuli. A linear RGD peptide, a recombinant fi bronectin fragment containing the seven to ten Type III repeats (FnIII7-10) and a triple helical, collagen mimetic peptide with the GFOGER motif were covalently coupled to agarose gels using the sulfo-SANPAH crosslinker, and bone marrow stromal cells (BMSCs) were cultured within the 3D hydrogels. The ligands retained biologic functionality within the agarose gels and promoted density-dependent BMSC spreading. Interactions with all adhesive ligands inhibited stimulation by chondrogenic factors of collagen Type II and aggrecan mRNA levels and deposition of sulfated glycosaminoglycans. In medium containing fetal bovine serum, interactions with the GFOGER peptide enhanced mRNA expression of the osteogenic gene osteocalcin whereas FnIII7-10 inhibited osteocalcin expression. In conclusion, modifi cation of agarose hydrogels with ECMmimetic ligands can infl uence the differentiation of BMSCs in a manner that depends strongly on the presence and nature of soluble biochemical stimuli.
Introduction
Mesenchymal stem cells (MSCs) are an attractive cell source for tissue engineering and cell-based therapies given their multilineage differentiation potential and ability to be expanded in culture (Caplan, 1991; Pittenger et al., 1999) . The repair of damaged articular cartilage is one particular application that would be well suited for MSCs as a result of the limited capacity for cartilage regeneration and the rapid dedifferentiation of chondrocytes during monolayer expansion (Benya and Shaffer, 1982) . Many populations of mesenchymal progenitors such as bone marrow stromal cells (BMSCs) display chondrogenic-like differentiation in three-dimensional (3D) culture environments and in the presence of transforming growth factor-β (TGF-β) family growth factors (Johnstone et al., 1998; Caterson et al., 2001; Bosnakovski et al., 2004) . However, recent studies have shown that even over extended culture periods, engineered cartilage constructs derived from BMSCs have a distinct composition and inferior mechanical properties compared with those derived from native articular chondrocytes (Mauck et al., 2006; Connelly et al., 2008b) . It is therefore likely that additional signals are required for complete chondrogenic differentiation and the development of a functional tissue replacement.
Interactions between cells and the extracellular matrix (ECM) provide important cues for the differentiation and development of many tissues, including cartilage. For example, integrin-mediated adhesion to fi bronectin is required for precartilage condensation of limb bud cells (Bang et al., 2000) , and the presence of specifi c fi bronectin isoforms infl uences the extent of condensation (White et al., 2003) . Interactions with Type II collagen can also enhance the in vitro chondrogenesis of BMSCs (Bosnakovski et al., 2006) . Although much work is still required to fully understand the complex roles of cellmatrix interactions in chondrogenesis, it is clear that the ECM provides key signals for guiding this process.
A potential strategy for controlling cell-matrix interactions in vitro is to engineer synthetic matrices to present specific ligands in a precise manner. The incorporation of peptides containing the integrin adhesive sequence Arginine-Glycine-Aspartic acid (RGD) into non-adhesive hydrogels was reported to enhance MSC survival and osteogenic differentiation (Shin et al., 2005) . However, studies in our laboratory suggest that alginate and agarose hydrogels functionalized with RGD peptides inhibit BMSC chondrogenesis (Connelly et al., JT Connelly et al. Ligands regulate chondrogenesis in 3D hydrogels 2007; Connelly et al., 2008a) . In addition to modulating integrin-mediated adhesion, engineered matrices also provide a means for introducing small molecules (Benoit et al., 2008) or larger moieties such as chondroitin sulfate (Varghese et al., 2008) that can enhance in vitro chondrogenesis. Although interactions with the RGD motif inhibit BMSC chondrogenesis, interactions with adhesive sequences that mimic other ECM proteins and target a distinct set of integrin receptors may induce different responses. For example, α5β1 binding to fibronectin requires a synergy site containing the "PHSRN" sequence in addition to RGD (Aota et al., 1994) , and α2β1 binds to the "GFOGER" motif within fi brillar collagens (Reyes and Garcia, 2003) . However, the effects of ECM-mimetic ligands with complex secondary and tertiary structures on chondrogenesis are unknown. The goals of this study were to determine whether fi bronectin-and collagen-mimetic ligands, targeting the α5β1 integrins and α2β1 integrins, respectively, retain biologic functionality when conjugated to 3D agarose hydrogels, whether interactions with different ECM-mimetic ligands differentially infl uence BMSC chondrogenesis in 3D hydrogels, and whether the responses to such engineered matrices depend on the nature of soluble biochemical stimuli presented through the culture medium.
FIBRONECTIN-AND COLLAGEN-MIMETIC LIGANDS REGULATE BONE MARROW STROMAL CELL CHONDROGENESIS IN THREE-DIMENSIONAL HYDROGELS

Materials and Methods
Materials
The synthetic peptides GRGDSP (RGD) and the non-adhesive control GRGESP (RGE) were obtained from Bachem H-proline and ECF substrate were purchased from GE Healthcare (Piscataway, NJ, USA). The anti-vinculin and anti-biotin antibodies were from Sigma-Aldrich, and the FITC anti-mouse antibody was from Abcam (Cambridge, UK). AlexaFluor 594-conjugated phalloidin was from Molecular Probes (Eugene, OR, USA). The RNeasy mini kit was from Qiagen (Valencia, CA, USA), and the AMV reverse transcriptase kit was from Promega (Madison, WI, USA). The Sybr Green master mix was from Applied Biosystems (Foster City, CA, USA), and the primers were from Invitrogen.
Preparation of ligand-modifi ed agarose
A monobiotinylated fi bronectin fragment containing the seventh to tenth Type III repeats (FnIII7-10) of human fi bronectin was expressed in JM109 cells and purifi ed by affi nity chromatography as previously described (Petrie et al., 2006) . A biotin tag was coupled to the cysteines in the GFOGER peptide using the EZ-link Maleimide-PEGBiotin kit according to the manufacturer's instructions. The synthetic peptides and fi bronectin fragment were then conjugated to agarose hydrogels with the heterobifunctional sulfo-SANPAH crosslinker (Dodla and Bellamkonda, 2006) . Briefl y, the primary amines on the ligands were reacted with the NHS-ester group of the sulfo-SANPAH in PBS at room temperature for 4 h in the dark with a 10-fold molar excess of the crosslinker. Seaprep agarose solutions were prepared in Ca 2+ /Mg 2+ -free PBS, autoclaved, and cooled to 37 ºC. One part peptide/sulfo-SANPAH solution was combined with three parts 4 % agarose and mixed thoroughly to yield a 3 % agarose solution. The mixture was exposed to 365 nm ultraviolet light for 3 min to activate the photoreactive groups of the sulfo-SANPAH and conjugate the peptide to CH groups in the agarose. The agarose was allowed to gel at 4 ºC for 20 min and washed four times with fi vefold excess PBS over 3 days to remove the unbound peptide and crosslinker. Controls were prepared as stated previously but without addition of the sulfo-SANPAH. Final ligand densities in the agarose gels were determined by dot blot detection of biotinylated ligands (Fig. 1 ). Gels were digested with agarase (4 U/ gel) at 45 ºC for 4 h and blotted onto nitrocellulose (n = 3/condition). Membranes were probed with alkaline phosphatase-conjugated anti-biotin antibodies and developed with the ECF substrate and Fuji Image Analyzer (Fuji, Tokyo, Japan). For an input concentration of 8 μM (400 μg/mL) FnIII7-10, the conjugation effi ciency was approximately 30 %, resulting in a fi nal density of 2.4 μM ( Fig 1C) . For an input density of 37 μM (200 μg/mL) GFOGER, the conjugation effi ciency was approximately 20 %, resulting in a fi nal density of 7.4 μM (Fig. 1C ). Low levels (less than 5 %) of the ligands were present in gels without the sulfo-SANPAH crosslinker. For reference, the conjugation effi ciencies for the fi bronectin-and collagenmimetic ligands were slightly higher than those previously reported for laminin-1 (Dodla and Bellamkonda, 2006).
Cell seeding and gel culture
Bone marrow was harvested from the tibiae and femora of an immature calf as previously described (Connelly et al., 2007) . The adherent BMSCs were expanded three times in low-glucose DMEM supplemented with 10 % fetal bovine serum (FBS) and 1 ng/mL bFGF. The 3 % modifi ed agarose gels were melted at 45 ºC and cooled to 37 ºC. BMSCs were then seeded into cylindrical (4 mm diameter) gels by resuspending the cells in the melted agarose at a density of 10e6 cells/mL and casting the cell suspension into JT Connelly et al. Ligands regulate chondrogenesis in 3D hydrogels custom molds. The gels were cooled at 4 ºC for 30 min and transferred to fresh culture medium. The basal, chemically defi ned medium consisted of high-glucose DMEM, 1 % ITS+ Premix, 1 % NEAA, 1 % antibiotic/antimycotic, and 50 μg/mL ascorbate. The chondrogenic medium was basal medium supplemented with 10 ng/mL TGF-β1 and 100 nM dexamethasone. The FBS-supplemented medium consisted of DMEM, 10 % FBS, 1 % NEAA, 1 % antibiotic/ antimycotic, and 50 μg/mL ascorbate. BMSC seeded gels were cultured up to 8 days under the specifi ed conditions and media were changed every 2 days.
Ligand functionality
To examine the functionality of the ligands in the 3D hydrogels, BMSCs were seeded into agarose gels functionalized with the RGD peptide (0, 50, and 100 μM), FnIII7-10 fragment (0, 0.5, and 1 μM), GFOGER peptide (0, 3.75, 15 μM), or nonadhesive RGE peptide (100 μM). Cells in gels were cultured for 24 h in basal medium and examined for changes in cell morphology. Agarose gels were fi xed with 10 % neutral-buffered formalin for 30 min at 4 ºC and rinsed in PBS. Portions of the fi xed gels were blocked with 5 % FBS and permeabilized with 1 % Triton-X100. Vinculin localization was examined by staining with the anti-vinculin antibody (10 μg/mL) for 90 min at room temperature and secondary detection was performed with the anti-mouse FITC-labeled antibody (10 μg/mL) for 90 min at room temperature. The F-actin cytoskeleton was visualized by staining with AlexaFluor594-phalloidin for 90 min at room temperature, Fig. 1 . Conjugation of FnIII7-10 and GFOGER ligands to agarose hydrogels. (a) FnIII7-10 and (b) GFOGER densities in the agarose gels were determined by dot blot detection of the biotin tag after agarase digestion. The initial concentration of FnIII7-10 and GFOGER were 400 μg/mL (8 mM) and 200 μg/mL (37 mM), respectively, and the standards were diluted from the ligand stocks. Control gels were prepared with the same initial ligand density but without the sulfo-SANPAH crosslinker. (c) Conjugation effi ciency for the FnIII7-10 and GFOGER modifi ed gels was quantifi ed by measuring the dot blot intensities relative to the initial densities. For the concentrations examined, there was a linear relationship between biotin intensity and ligand concentration. Data represent the mean ± SEM, n = 3 gels per condition.
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and DNA was labeled with Hoechst dye. The agarose gels were imaged with a Zeiss 510 laser scanning confocal microscope (Zeiss, Heidelberg, Germany). Fluorescence images of the F-actin cytoskeleton from two different gels (three images per gel) were analyzed with Scion Image software (Frederick, MD, USA). The area (A) and perimeter (P) for each individual cell were used to calculate the circularity (circularity = 4πA/P 2 ) as a quantitative measure of cell spreading with a lower circularity indicating a greater degree of spreading (Connelly et al., 2008a) .
Effects of ligands on BMSC differentiation
To investigate the effects of these ligand-functionalized gels on chondrogenic differentiation, BMSCs were fi rst seeded into RGE (100 μM), RGD (100 μM), FnIII7-10 (1 μM), or GFOGER (15 μM) modifi ed agarose, cultured for 8 days in basal or chondrogenic medium, and examined for changes in matrix synthesis rates and accumulation (n = 5/ group). To determine the lineage-specifi c effects of the gels, BMSCs were again seeded into RGE, RGD, FnIII7-10, or GFOGER modifi ed agarose with the same ligand densities as in the chondrogenic experiment, cultured for 8 days in chondrogenic or serum supplemented medium, and examined for changes in chondrocytic and osteoblastic gene expression (n = 4/group).
During the fi nal 24 h of culture, 5 μCi/mL 35 S-sodium sulfate and 10 μCi/mL 3 H-proline were included in the culture medium to measure sulfated glycosaminoglycan (sGAG) and protein synthesis, respectively. At the end of the culture period, radiolabel incorporation was quenched with four sequential 30 min washes in PBS plus 0.8 mM sodium sulfate and 1.6 mM L-proline at 4 °C. The agarose gel constructs were weighed wet, lyophilized, and sequentially digested with Proteinase K (1 mg/80 mg sample) at 60 ºC overnight and agarase (4 U/construct) at 45 ºC for 4 h. Radiolabel contents were measured using a liquid scintillation counter. The sGAG contents were measured using the 1,9-dimethylmethylene blue assay (Farndale et al., 1982) , and the DNA contents were measured using the Hoechst dye assay (Kim et al., 1988) . Total collagen content was measured using the hydroxyproline assay (Woessner, 1961) .
RNA was isolated from the agarose gels using the Tri-spin method (Chomczynski and Sacchi, 1987) . Gels were immediately dissociated in lysis buffer containing 2-mercaptoethanol. RNA was extracted from the gel using the Trizol reagent and chloroform and precipitated with 100 % isoproponol. The RNA was further purifi ed using the Qiagen RNeasy kit according to the manufacturer's protocol. Total RNA (1 μg) was reverse-transcribed to cDNA using the Promega AMV reverse transcriptase kit. Gene expression was measured by real-time reverse transcription-polymerase chain reaction (PCR) using the SybrGreen master mix and custom primers for bovine collagen II, aggrecan, collagen I (Brodkin et al., 2004) , and osteocalcin (Bosnakovski et al., 2005) . The PCR reactions and detection were performed with an ABI Prism 7700 (Applied Biosystems) and the transcript number relative to total RNA was calculated based on standards of known concentrations run on the same plate.
Data analysis
All data are presented as the mean ± SEM (standard error of the mean) of representative experiments. Gene expression levels were transformed by optimal Box-Cox transformation to improve normality (Sokal and Rohlf, 1995) . The effects of ligands in the presence or absence Fig. 2 . Effects of ligand-modifi ed agarose on bone marrow stromal cell (BMSC) morphology. (a) BMSC morphology was examined 24 h after seeding into functionalized gels by immunofl uorescence detection of the F-actin cytoskeleton (red), vinculin (green), and DNA (blue). Agarose gels were modifi ed with 100 μM RGE, 100 μM RGD, 0.5 μM FnIII7-10, and 15 μM GFOGER (fi nal densities). Scale bars are 50 μm. (b) Three-dimensional cell morphology was quantifi ed by measuring the fraction of spread cells (circularity greater than 0.75) over a range of ligand densities for RGD, FnIII7-10 (inset), and GFOGER. Data represent the mean ± SEM, n = 6 (Original magnifi cation, 10x).
a: Cell Morphology b: Cell Spreading
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of chondrogenic supplements on matrix synthesis rates and sGAG accumulation were examined using two factor (ligand, medium) general linear models with Tukey's test for pairwise comparisons. The effects of ligands on chondrocytic and osteoblastic gene expression in chondrogenic or serum-supplemented medium were examined using two factor (ligand, medium) general linear models with Tukey's test for pairwise comparisons.
Signifi cance was at p < 0.05.
Results
Integrin adhesive ligands alter BMSC morphology in 3D agarose gels
Like the linear RGD peptide, the recombinant fi bronectin fragment FnIII7-10 and collagen-mimetic peptide containing the GFOGER sequence retained biologic functionality after conjugation to the agarose. After 24 h, BMSCs in the non-adhesive RGE hydrogels maintained a rounded morphology. In contrast, cells in hydrogels conjugated with RGD, FnIII7-10, and GFOGER demonstrated marked changes in morphology characterized by large F-actin projections and positive staining for vinculin ( Fig. 2A) , consistent with integrinmediated adhesion to the hydrogel. For each of the adhesive molecules, there was a monotonic increase in the number of spread cells with increasing ligand density (Fig. 2B) . On a molar basis, FNIII7-10 was the most effective at inducing cell spreading, whereas RGD was the least effective. Similar changes in cell morphology at 24 h were observed for 100 μM RGD, 1 μM FnIII7-10, and 15 μM GFOGER. 
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Interactions with FnIII7-10 and GFOGER inhibit matrix production during BMSC chondrogenesis At concentrations inducing comparable degrees of cell spreading at 24 h, all three adhesive ligands inhibited stimulation of ECM production by chondrogenic medium. Compared to basal medium, chondrogenic medium stimulated sGAG synthesis on day 8 (as measured by 35 S-sulfate incorporation) and sGAG accumulation within the agarose gels over the 8 day culture (both p < 0.0001). Compared with unmodifi ed gels, these responses were both inhibited by the presence of RGD, FnIII7-10 or GFOGER (all p < 0.0001) (Fig. 3A,B) . The chondrogenic medium also stimulated overall protein synthesis on day 8 (as measured by 3 H-proline incorporation) and collagen accumulation over the 8 day culture (both p < 0.0001). Compared with unmodifi ed gels, interactions with RGD (p = 0.0007) or FnIII7-10 (p < 0.0001) inhibited protein synthesis, and interaction with RGD (p = 0.018), FnIII7-10 (p < 0.0001), or GFOGER (p < 0.0001) inhibited collagen accumulation (Fig. 3C,D) . The RGE peptide did not substantially alter matrix synthesis rates or accumulation, as only the sGAG synthesis rate was significantly different from unmodifi ed gels (p = 0.002). The presence of FnIII7-10 substantially increased (p = 0.022) collagen deposition in basal medium (Fig. 3D) .
Interactions with functionalized hydrogels infl uence lineage-specifi c gene expression in a context dependent manner
The effects of the adhesive ligands on BMSC gene expression differed depending on the biochemical cues present in the culture medium. After 8 days of culture in the presence of the chondrogenic stimuli TGF-β1 and dexamethasone, interactions with RGD, FnIII7-10 Fig. 4 . Effects of ligand modifi ed agarose on lineage-specifi c gene expression. Levels of mRNA for the chondrocytic genes (a) Type II collagen and (b) aggrecan were measured by real-time polymerase chain reaction after 8 days of culture in RGE, RGD, FnIII7-10, or GFOGER modifi ed agarose. Gels were cultured in chondrogenic medium or basal medium supplemented with 10 % FBS. Expression of (c) Type I collagen and the osteogenic marker (d) osteocalcin were also measured at day 8. Data represent the mean ± SEM, n = 4-6 gels/condition, and are presented on a logarithmic scale. Signifi cance vs. chondrogenic for a given gel is indicated by * (p < 0.0001), + (p < 0.001) or § (p < 0.05).
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or GFOGER all inhibited mRNA levels ( Fig. 4A-B) of the chondrocytic genes Type II collagen (all p < 0.0001) and aggrecan (p = 0.0064, p < 0.0001 and p = 0.0001, respectively). In contrast, expression of collagen II was substantially lower after 8 days of culture in 10 % FBSsupplemented medium than in chondrogenic medium for all gel groups (all p < 0.0001) and was not signifi cantly affected by the presence of any of the adhesive ligands. In serum-supplemented medium, expression of aggrecan was signifi cantly lower than in chondrogenic medium for RGE-modifi ed gels only (p = 0.009), and was inhibited by interactions with FnIII7-10 (p = 0.0018). Type I collagen expression (Fig. 4C) did not signifi cantly differ between chondrogenic and serum-supplemented medium in gels modifi ed with RGE or FnIII7-10, but was signifi cantly greater in serum-supplemented medium in gels modifi ed with RGD (p = 0.002) or GFOGER (p = 0.025). Relative to RGE-modifi ed gels, collagen I expression was stimulated only by interactions with RGD in serum-supplemented medium (p < 0.0001), and was inhibited by interactions with FnIII7-10 in serum-supplemented medium and GFOGER in chondrogenic medium (both p < 0.0001). Expression of the osteogenic marker osteocalcin (Fig. 4D ) was substantially higher in serum-supplemented medium compared with the chondrogenic medium in gels modifi ed with RGE, RGD or GFOGER (all p < 0.0001), and did not signifi cantly vary among ligands in chondrogenic medium. In serum-supplemented medium, osteocalcin expression was enhanced by RGD (p < 0.0001) or GFOGER (p = 0.0011) interactions and inhibited by FnIII7-10 interactions (p < 0.0001).
Discussion
Our data demonstrate that ECM-mimetic ligands with complex secondary and tertiary structures can be coupled to agarose hydrogels and retain their biologic activity. Similar to short, RGD containing oligopeptides (Connelly et al., 2008a) , GFOGER and FnIII7-10 promoted densitydependent changes in the three-dimensional morphology of BMSCs. On stimulation with the chondrogenic factors TGF-β1 and dexamethasone, the presence of each of the adhesive ligands inhibited matrix synthesis and chondrocytic gene expression relative to non-adhesive controls. Several studies found that adhesion to short RGD peptides inhibits the chondrogenesis of BMSCs (Connelly et al., 2007; Salinas and Anseth, 2008) and that this effect is mediated by the actin cytoskeleton (Connelly et al., 2008a) . Our data provide additional support for the role of the cytoskeleton and suggest that cell shape, more so than the specifi c integrin ligand, is a key regulator of chondrogenesis. Similarly, surface chemistry has less of an effect on human MSC chondrogenesis than overall morphology and cell aggregation (Phillips et al., 2010) . In contrast, the RGD and GFOGER ligands increased expression of osteocalcin, an osteoblastic gene, in the presence of 10 % FBS, whereas the FnIII7-10 inhibited this response. Taken together, these fi ndings indicate that the specifi c responses of BMSCs to cues supplied by engineered three-dimensional matrices depend on the biochemical environment. Although cell shape and cytoskeletal tension also control osteogenic versus adipogenic differentiation (McBeath et al., 2004; Engler et al., 2006) , our fi ndings and others further suggest that osteogenic differentiation may depend on the specifi c ECM and integrins involved (Keselowsky et al., 2005) . It is interesting to note that the RGD peptide, but not GFOGER or FnIII7-10, increased collagen I expression in the serum supplemented medium. These results raise the intriguing possibility that different components of the ECM may regulate different aspects of osteoblastic differentiation.
When coupled to biomaterial surfaces, the FnIII7-10 and GFOGER ligands enhance the osteoblastic differentiation of rat MSCs in vitro and the osseointegration of titanium screws in vivo (Reyes et al., 2007; Petrie et al., 2008) . Although the effects of the GFOGER modifi ed gels on osteocalcin expression in the present study are consistent with these fi ndings, the inhibitory effects of FnIII7-10 appear somewhat contradictory. Such differences may refl ect variations in the specifi c media formulation, which have the potential to alter cellular responses to biomaterials. For example, the presence of a phosphate source, which was absent in our culture medium, may impact the extent of osteogenesis. Alternatively, altered presentation of the FnIII7-10 between two-dimensional and three-dimensional may infl uence the activity and integrin specifi city of the ligand. Much work is clearly still required to understand the complex and context-dependent roles of cell-ECM interactions in differentiation, and new insights in this area could lead to improved biomaterials and regenerative therapies.
Although functionalizing hydrogels with ECM mimetic ligands may be detrimental for in vitro chondrogenesis, this strategy may be advantageous for other tissue engineering applications. Adhesion to RGD peptides can enhance initial cell viability within gels, and the incorporation of enzymatically cleavable tethers allows these ligands to be removed during later stages of differentiation (Salinas and Anseth, 2008; Kloxin et al., 2009) . Patterning of adhesive ligands may also allow for undifferentiated progenitors to be retained within specifi ed regions of an engineered tissue. Finally, graded levels of bioactive molecules could be a useful strategy for engineered heterogeneous tissues or interfaces such as fi brocartilage or osteochondral replacements, where controlling the extent of the chondrogenic response to initial biochemical cues may allow the development of tissues with desired spatial patterns of phenotypic heterogeneity. JT Connelly et al. Ligands regulate chondrogenesis in 3D hydrogels JT Connelly et al. Ligands regulate chondrogenesis in 3D hydrogels Connelly et al., 2008a, text references) . Furthermore, we have recently observed reduced chondrogenic gene expression and matrix production by human BMSCs in (adhesive) fibrin gels relative to (non-adhesive) alginate gels (unpublished). We are thus fairly confi dent in our general fi ndings. The issue of donor variability is an important one of substantial relevance to clinical implementation of stem cell-based therapies, but will be more appropriately explored for human donors.
Reviewer II:
The main results the authors present demonstrate that these ligands are not suitable for 3D chondrogenesis in hydrogels. Their discussion of the likely reasons is sound and reasonable, but is it likely that anybody would wish to attempt this approach? There are some potentially interesting fi ndings in relation to the osteogenesis specifi c genes. However, much further work would be warranted to elucidate the mechanisms of action. Please comment! Authors: We believe that the results of this study are interesting and relevant for several reasons. First, assuming that the only relevant goal is the generation of an engineered articular cartilage, information on strategies that do not produce a favorable outcome are just as valuable as information on strategies producing a desired effect. Results indicating that a strategy does not "work," particularly if they arise from well controlled, carefully executed studies, are quite important to the fi eld as a whole. A focus purely on what "worked," rather than on understanding how or why one approach works while another does not, was an endemic problem in the early development of tissue engineering as a discipline. Second, we believe that these results are quite relevant. Adhesive scaffolds (both engineered and natural proteinbased) are widely used in tissue engineering studies, including many studies on chondrogenesis. Our results are highly relevant to understanding cell behaviors in a wide range of scaffolds currently under investigation and may aid in the improvement of those scaffolds or understanding the tradeoffs involved in using such scaffolds. The fact that ligands targeting different integrins all inhibit chondrogenesis suggests that this should be a general concern for chondrogenesis in any scaffold material providing integrin binding domains. Furthermore, identifi cation of aspects of the cellular environment that inhibit chondrogenesis has bearing on understanding potential reasons for inadequate chondrogenesis in clinical treatments such as microfracture.
Third, we disagree with the notion that approaches that do not directly enhance the extent of hyaline-like chondrogenesis are inherently not useful or interesting, as there are situations in which inhibition of chondrogenesis may in fact be a desirable or necessary outcome. For example, the cells from fi brocartilaginous tissues such as the knee meniscus, temporomandibular joint disc, acetabular labrum, and annulus fi brosus are similar to, but not identical to, articular chondrocytes, and furthermore display notable regional heterogeneity. Most current tissue engineering approaches to such tissues are similar to those employed for articular cartilage, and do not involve approaches designed to specifically promote fibrocartilaginous differentiation. Understanding how to tune the chondrogenic differentiation of progenitors with instructive scaffolds may in fact be quite useful for engineering non-hyaline cartilages.
Regarding the effects on osteogenic genes, we agree that this is interesting (as noted in the discussion). However, exploration of the differential effects of different ligands on osteogenesis is a separate issue well beyond the scope of this study.
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